Deciphera Pharmaceuticals, Inc. Payments for Tenant Improvements
Deciphera Pharmaceuticals, Inc. reported Payments for Tenant Improvements of $2.70 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForTenantImprovements · last filed 2019-03-14
- Deciphera Pharmaceuticals, Inc. payments for tenant improvements for fiscal 2018 was $2.70M.
| Period end | Payments for Tenant Improvements 12 month |
|---|---|
| 2018-12-31 | $2.70M 10-K · filed 2019-03-14 |